mebeverine: Clinical Trials

9 trials of mebeverine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 3, 3 Phase 4, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 33Active not recruiting 1, Completed 1, Recruiting 1
Phase 43Completed 3
Not applicable2Completed 1, Not yet recruiting 1

Follow mebeverine: new trials by email Literature Review of mebeverine trials Research Report on mebeverine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ebastine Versus Mebeverine in IBS Patients
Ebastine, Duspatalin - IBS - Irritable Bowel Syndrome, IBS
Phase 3Active not recruitingGuy Boeckxstaens2002023-03-302026-09-11
To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
Rifaximin 550 MG, Mebeverine 135 MG, Psyllium Husk - Irritable Bowel Syndrome With Diarrhea
Phase 4CompletedBahria University1622023-01-032023-07-27
The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
alverine-citrate + simethicone and lactase, alverin-citrate + simethicone with placebo - Irritable Bowel Syndrome, Lactose Intolerance
Not applicableNot yet recruitingUniversity of Pecs2002022-09-012021-10-29
Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders
Mebeverine+Simethicone, Mebeverine, Simethicone - Functional Bowel Disorder
Phase 3CompletedAbbott4652020-11-272025-09-16
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
pentoxyifylline, Mebeverine, ethosuximide - IBS - Irritable Bowel Syndrome
Phase 3RecruitingTanta University602019-11-012020-01-03
Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute
mebeverine 200 mg sustained-release (Coloverine® SR, Chemipharm pharmaceutical, Egypt) one time/day at the evening., Placebo - Incontinence, Urinary Incontinence
Not applicableCompletedMansoura University1202019-03-012020-11-19
Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders
Coloverin, Placebo - Oncology, Incontinence
Phase 4CompletedMansoura University1102017-05-152020-06-30
Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointestinal Spasm
Mebeverine - Post-cholecystectomy Gastrointestinal Spasms
CompletedAbbott2202015-07-012019-06-06
Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial)
mebeverine, methylcellulose, placebo - Irritable Bowel Syndrome
Phase 4CompletedHazel Everitt1352010-04-012021-04-30

Conditions studied

Irritable Bowel Syndrome (5)  ·  Abdominal Pain (2)  ·  Urinary Bladder Neoplasms (2)  ·  Diarrhea (1)  ·  Diurnal Enuresis (1)  ·  Dyspepsia (1)  ·  Flatulence (1)  ·  Lactose Intolerance (1)  ·  Neoplasms (1)  ·  Nocturnal Enuresis (1)  ·  Urinary Incontinence (1)

Sponsors

Abbott (2)  ·  Mansoura University (2)  ·  Bahria University (1)  ·  Guy Boeckxstaens (1)  ·  Hazel Everitt (1)  ·  Tanta University (1)  ·  University of Pecs (1)

Countries

Egypt (3)  ·  Russia (2)  ·  Belgium (1)  ·  Hungary (1)  ·  Pakistan (1)  ·  United Kingdom (1)

Top investigators

Ahmed Elhussein, MBBCH (1)  ·  Ahmed Elkarta, MBBCH (1)  ·  Ahmed Mosbah, MD (1)  ·  Guy Boeckxstaens, prof. dr. (1)  ·  Hassan Abol-Enein, MD (1)  ·  Hazel A Everitt, MBChB (1)  ·  Mohamed Soltan, MBBCH (1)  ·  Rashid Ali (1)  ·  Sahar El-Haggar, Prof (1)  ·  Sahar Hegazy, Prof. (1)  ·  Sherief Abd-Elsalam, Ass. Prof. (1)  ·  Tatiana Vladimirova, MD, PhD (1)

Results publications

PMID 21087463, PMID 23602047, PMID 27144617, PMID 34726293, PMID 35221706

NIH funding

2009 (1)